NHNick Harris

Nick Harris

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nick Harris has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Jennifer Donnan

    Memorial University of Newfoundland

    3 shared publications
  • Laura M. Harris-Lane

    Department of Psychology, Memorial University of Newfoundland, St. John’s, Canada

    3 shared publications
  • Dalainey H. Drakes

    Department of Psychology, Memorial University of Newfoundland, St. John's, Newfoundland, Canada; School of Pharmacy, Memorial University of Newfoundland, St. John's, Newfoundland, Canada

    2 shared publications
  • David Paul Storey

    Affiliations Department of Psychology, Memorial University of Newfoundland, St. John’s, NL, Canada, Memorial University of Newfoundland Behavioural Medicine Centre (MUN-BMC), Memorial University of Newfoundland, St. John’s, NL, Canada

    2 shared publications
  • Gregory K. Tippin

    Dept. of Psychology Memorial University of Newfoundland St. John's NL Canada

    2 shared publications
  • Joshua A. Rash

    Department of Psychology, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada

    2 shared publications

Latest Publications

  • Open Access

    Reducing medical cannabis use risk among Veterans: A descriptive study

    by Laura M. Harris-Lane, Mitchell Sheehy, Courtney A. Loveless, Joshua A. Rash, David P. Storey, Gregory K. Tippin, Vikas Parihar, Nick Harris

    Canadian Veterans experiencing chronic pain report concerns about accessing accurate information on the risks associated with medical cannabis (MC) use. The Lower Risk Cannabis Use Guidelines (LRCUG) were developed to equip individuals who use cannabis recreationally with safer-use strategies. Many of the harm reduction recommendations for recreational cannabis use are relevant and important considerations for MC use. The primary objective of our study was to assess Canadian Veterans’ awareness of and interest in the LRCUG, and engagement in potential higher-risk MC use behaviours. Canadian Armed Forces Veterans living with chronic pain (N = 582) were recruited online and through the Chronic Pain Centre of Excellence for Canadian Veterans. Participants completed measures on: cannabis use (never, past, current use), sources of cannabis knowledge, mental health, and awareness of and interest in receiving the LRCUG. Chi-Square and post-hoc analyses characterized the sample and assessed for demographic differences based on cannabis use status and awareness of the LRCUG. Engagement in higher-risk MC use behaviours were aligned to LRCUG recommendations, and detailed descriptively. Veterans who currently use cannabis were more likely to be unemployed (z = 3.62, p < .01), released as a Non-Commissioned Officer (z = -3.83, p < .01), and unable to work due a disability (z = -3.43, p < .01) than Veterans who do not currently use. Less than 30% of Veterans were aware of the LRCUG, with greater awareness among individuals who currently use cannabis (n = 356). Engagement in higher-risk MC use behaviours that contradicted LRCUG recommendations ranged from ~ 9% to ~ 85%. Approximately 9% of Veterans experienced co-morbid mental health concerns, yet their MC use was not for mental health purposes (LRCUG recommendation #7). Additionally, almost 85% of Veterans engaged in daily MC use (LRCUG recommendation #5). The majority of Veterans who currently use cannabis engaged in two or more higher-risk MC use behaviours (60.2%; LRCUG recommendation #12). Almost half of all Veterans received their cannabis information from a healthcare provider or the internet. Our study suggests the importance of safer use guidelines tailored for MC use. Development of lower-risk MC use guidelines can support prescribing practitioners and Veterans with information needed for safer and better-informed MC use decisions, tailored to patients’ needs and circumstances.


  • Open Access

    Cannabis Use Characteristics and PTSD-Related Outcomes Among Canadian Veterans With Chronic Pain

    by Mitchell R. Sheehy, David P. Storey, Joshua A. Rash, Greg K. Tippin, Vikas Parihar, Nick Harris

    Previous research on the relationship between cannabis and posttraumatic stress disorder (PTSD) has produced equivocal results. One explanation is that differences in cannabis use characteristics (e.g., medicinal vs. recreational use, route of administration, THC to CBD ratio, and grams per day) are associated with differences in PTSD severity. Using data from a previous cross-sectional study, we performed a series of MANOVAs to examine how cannabis use, cannabis use characteristics, sex, and talk therapy attendance are associated with PTSD severity, psychological distress (i.e., depression and anxiety), and insomnia in a sample of Canadian veterans with chronic pain and a history of trauma (N = 513). We also performed descriptive analysis on participants’ demographics, military history, and cannabis use. Participants with a cannabis prescription and/or who attended talk therapy tended to have higher PTSD severity than those who did not. Cannabis use, sex, route of administration, THC to CBD ratio, and grams per day, were not significantly correlated with PTSD-related outcomes. However, descriptive analysis showed that the majority of those who used cannabis reported that it benefited their mental health. We speculate that veterans with more severe PTSD are more likely to seek out treatment in the form of prescribed cannabis or talk therapy; and that the perceived effect of cannabis on PTSD differs from the measured effect due to cannabis only causing a short-term reduction in PTSD symptoms.


  • A Cross Sectional Survey of Factors Related to Cannabis Use as a Sleep Aid Among Canadian Cancer Survivors

    by Rachel M. Lee, Jennifer Donnan, Nick Harris, Sheila N. Garland

    Poor sleep is a common side effect of cancer. Cannabis is increasingly used to manage cancer treatment-related symptoms, including sleep. This study investigated factors related to cannabis use for sleep among Canadian cancer survivors. Adult Canadian cancer survivors (N = 940) were recruited via the Angus Reid Institute and completed an online, cross-sectional survey. Univariate and multiple binomial logistic regression models identified factors associated with cannabis use for sleep. Of the participants (Mage = 64.5 yrs; Women = 51.1%; White = 92.9%), 25.1% (n = 236) currently use cannabis for sleep. Participants were at greater odds of using cannabis for sleep if they identified as a gender other than man or woman (AOR = 11.132), were diagnosed with multiple medical conditions (2:AOR = 1.988; 3+:AOR = 1.902), two psychological conditions (AOR = 2.171), multiple sleep disorders (AOR = 2.338), insomnia (AOR = 1.942), bone (AOR = 6.535), gastrointestinal (AOR = 4.307), genitourinary (AOR = 2.586), hematological (AOR = 4.739), or an unlisted cancer (AOR = 3.470), received hormone therapy only (AOR = 3.054), drink heavily (AOR = 2.748), or had mild insomnia (AOR = 1.828). Older participants (AOR=.972) and those with sleep apnea were less likely to use cannabis for sleep (AOR=.560). Given its prevalence, research is needed to understand how factors associated with cannabis use as a sleep aid among Canadian cancer survivors may influence its use and effectiveness and whether these factors are barriers to accessing evidence-based treatments.

  • A cross-sectional survey of the prevalence and patterns of using cannabis as a sleep aid in Canadian cancer survivors

    by Rachel M. Lee, Jennifer Donnan, Nick Harris, Sheila N. Garland

    Purpose Poor sleep is one of the most common side effects of cancer. It can persist for years beyond treatment and negatively impact quality of life and health. Cannabis is increasingly used to manage cancer treatment-related symptoms, including sleep. This study investigated the use and perceived effects of cannabis as a sleep aid in Canadian cancer survivors. Methods Adult Canadian cancer survivors (N = 1464) were recruited via the Angus Reid Institute and completed an online, cross-sectional survey including the Insomnia Severity Index and questions about cannabis use for sleep. Standard descriptive statistics, such as means, standard deviations, and ranges were produced for measured variables to assess the ways cancer survivors use cannabis for sleep. Frequencies were tabulated for categorical and ordinal variables. Results On average, participants (Mage = 61.1 years; Women = 50%: Men = 48%) received their cancer diagnosis 12.5 years prior. Of participants, 23.5% (n = 344) currently use cannabis as a sleep aid, with reported benefits including relaxation, reduced time to fall asleep, fewer nocturnal awakenings and improved sleep quality. Two thirds (68.3%, n = 235) only began using cannabis for sleep after their cancer diagnosis. Over a third of participants (36.3%, n = 125) use cannabis as a sleep aid every day. Among the 344, the most common other reasons for using cannabis were pain (31.4%, n = 108), recreational use (24.4%, n = 84), and anxiety (12.5%, n = 43). Conclusions Given the prevalence and potential impact, research is needed to examine the actual efficacy of cannabis as a sleep aid. Implications for cancer survivors It is important that cancer survivors have information on methods to help their sleep to avoid impairments to quality of life and health.


  • Open Access

    Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study

    by David P. Storey, Natalie R. Keeler-Villa, Nick Harris, Jennifer Anthonypillai, Gregory K. Tippin, Vikas Parihar, Joshua A. Rash

    During fiscal year 2021–2022, Veterans Affairs Canada (VAC) reimbursed 18,388 veterans for medicinal cannabis at a cost of $153 million. Yet, it is not known whether the reimbursement program is producing a net benefit for veterans. This study investigated the views and experiences Canadian that veterans who live with pain have about medicinal cannabis use, including its use for the management of chronic pain, poor sleep, and emotional distress. Twelve Canadian veterans who live with pain—eight men, four women; split across four focus groups—were recruited to participate in a semistructured discussion around their experiences with medicinal cannabis use. Using inductive thematic analysis, seven broad categories were identified: (1) cannabis use behaviors, (2) reasons for cannabis use, (3) outcomes from cannabis use, (4) facilitators of cannabis use, (5) barriers to cannabis use, (6) stigma around cannabis use, and (7) questions and concerns about cannabis use. Most veterans initiated cannabis use to manage the symptoms of preexisting medical and/or mental health conditions. Despite some negative side effects, most veterans reported improvements in their overall quality of life, sleep, relationships, mood, and pain. Concern remains around the discrepancy between veterans’ qualitative reports of beneficial outcomes from medicinal cannabis use and equivocal findings around the benefit-to-harm ratio in the wider literature. Currently, the VAC reimbursement program remains challenged by unclear indication for which veterans, with what condition(s), at what dose, and in what form medical cannabis is most beneficial.


  • Open Access

    Emerging adult perceptions of higher-risk cannabis consumption behaviours

    by Isobel McMahon, Laura M. Harris-Lane, Jennifer Donnan, Lisa Bishop, Nick Harris

    Background: Emerging adults have the highest cannabis consumption rates in Canada and are among the most vulnerable to cannabis-related harms. Since certain cannabis consumption behaviours carry greater risks of harm, the Lower-Risk Cannabis Use Guidelines (LRCUG) provide harm reduction strategies. To address a critical gap in the literature, the current study examined emerging adults’ awareness of the guidelines and perceptions of higher-risk cannabis consumption behaviours identified within the LRCUG. Methods: Emerging adults (N = 653) between the ages of 18–25 years were recruited from across Canada. Participants were presented with five vignettes depicting a character’s cannabis consumption behaviours. Each vignette focused on a unique aspect of the character’s consumption (frequency, polysubstance use, family history of mental illness, method of consumption, and potency). Participants were randomly assigned to one of three conditions within each of the five vignettes that were altered to capture varying levels of risk (e.g. weekly, almost daily, or daily consumption). Following each vignette, participants were asked to respond to four items relating to overall risk of harm, cognitive health, physical health, and mental health. Results: Participants perceived: (1) frequent consumption to be associated with greater risks than less frequent consumption; (2) simultaneous consumption of cannabis and tobacco as being associated with higher risk of harm, yet no difference between simultaneous consumption of cannabis and alcohol or cannabis consumption alone; (3) consuming cannabis with a family history of psychosis or substance use disorder as being associated with greater overall risk than consumption with no family history; (4) smoking and vaping cannabis as associated with more risk than ingesting edibles; and (5) higher-potency THC-dominant strains as being associated with more risk than lower-potency CBD-dominant strains, yet no difference between the two higher-potency THC-dominant strains. Conclusions: While emerging adults seemed to appreciate the risks associated with some cannabis consumption behaviours, they had difficulty identifying appropriate levels of harm of other higher-risk behaviours. Through an improved understanding of emerging adult perceptions, effective education campaigns should be designed to improve the awareness of cannabis risks and encourage the uptake of harm reduction awareness and strategies.


  • Emerging Adult Perceptions of Cannabis Consumption Post-Legalization: Considering Age and Sex Differences

    by Laura M. Harris-Lane, Dalainey H. Drakes, Jennifer R. Donnan, Emily C. Rowe, Lisa D. Bishop, Nick Harris


  • Positive Mental Health in Youth with ADHD: Exploring the Role of Social Support

    by Laura Harris-Lane, Jacqueline Hesson, Ken Fowler, Nicholas Harris

    Positive mental health in youth has important implications for overall well-being. This study examined the extent to which different types of social support are associated with positive mental health among individuals, ages 15–24, diagnosed with attention deficit/hyperactivity disorder (ADHD). Compared to respondents without a diagnosis of ADHD, those with a diagnosis had significantly lower scores on measures of positive mental health and on four of five types of social support. Among the five types of social support, social integration and reassurance of worth were found to be significant predictors of positive mental health in respondents diagnosed with ADHD.